HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome

被引：0
|
作者：
Bottosso, Michele
Sandoval, Renata Lazari
Verret, Benjamin
Polidorio, Natalia
Caron, Olivier
Gennari, Alessandra
Bychkovsky, Brittany
Hyman, Sophie
Achatz, Maria Isabel
Guarneri, Valentina
Andre, Fabrice
Garbe, Judy
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P5-02-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-02-18
引用
收藏
页数：3
相关论文
共 50 条
  • [1] HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
    Bottosso, Michele
    Sandoval, Renata L.
    Verret, Benjamin
    Polidorio, Natalia
    Caron, Olivier
    Gennari, Alessandra
    Bychkovsky, Brittany L.
    Cahill, Sophie H.
    Achatz, Maria I.
    Guarneri, Valentina
    Andre, Fabrice
    Garber, Judy E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [2] HER2-low Status among Patients with Li-Fraumeni Syndrome and Breast Cancer
    Auresco, Luciana
    Bonadio, Renata Colombo
    Petry, Vanessa
    Testa, Laura
    Moniz, Camila
    Dos Santos, Jennifer
    Estevez-Diz, Maria Del Pilar
    Guindalini, Rodrigo Santa Cruz
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [3] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
  • [4] HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
    Novillo, Apolonia
    Gaibar, Maria
    Romero-Lorca, Alicia
    Malon, Diego
    Anton, Beatriz
    Moreno, Amalia
    Fernandez-Santander, Ana
    [J]. CANCERS, 2023, 15 (03)
  • [5] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Stanowicka-Grada, Malwina
    Senkus, Elzbieta
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (11) : 1633 - 1650
  • [6] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Malwina Stanowicka-Grada
    Elżbieta Senkus
    [J]. Current Treatment Options in Oncology, 2023, 24 : 1633 - 1650
  • [7] HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment
    Altundag, Kadri
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 261 - 261
  • [8] HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment
    Kadri Altundag
    [J]. Breast Cancer Research and Treatment, 2019, 175 : 261 - 261
  • [9] The HER2 CISH pharmDx™ Kit in the assessment of breast cancer patients for anti-HER2 treatment
    Foged, Niels T.
    Brugmann, Anja
    Jorgensen, Jan T.
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (03) : 233 - 242
  • [10] Stability of HER2 Expression in Residual Breast Cancer Following Neoadjuvant Anti-HER2 Therapy
    Mir, Mariam O.
    Sahoo, Sunati
    Fang, Yisheng
    Peng, Yan
    Hwang, Helena
    Czapla, Agata
    Koduru, Prasad
    Sarode, Venetia
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 91 - 91
12345